MoonLake Immunotherapeutics Class A Ordinary Shares
Symbol: MLTX (NASDAQ)
10.00
▲ (6.56%) 0.615
Company Description:
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
Key Stats
- Today's Open: $9.5
- Today's High: $10.56
- Today's Low: $9.361
- Today's Volume: 9.61M
- Yesterday Close: $9.38
- Yesterday High: $10.04
- Yesterday Low: $9.3
- Yesterday Volume: 7.75M
- Last Min Volume: 1.63K
- Last Min High: $9.995
- Last Min Low: $9.995
- Last Min VWAP: $9.995
Company Profile
- Name: MoonLake Immunotherapeutics Class A Ordinary Shares
- Website: https://www.moonlaketx.com
- Listed Date: 2022-04-06
- Location: ZUG, V8
- Market Status: Active
- CIK Number: 0001821586
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $651.52M
- Round Lot: 100
- Outstanding Shares: 63.50M
- Asset Type: CS
RECENT FILINGS FOR MLTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-09 | 4 | View |
| 2025-10-01 | SCHEDULE 13G/A | View |
| 2025-10-01 | 4 | View |
| 2025-09-29 | 8-K | View |
| 2025-09-04 | 4 | View |
| 2025-08-14 | SCHEDULE 13G | View |
| 2025-08-06 | SCHEDULE 13G/A | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-07-07 | 4 | View |
| 2025-07-03 | 144 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-06 | 8-K | View |
| 2025-05-14 | SCHEDULE 13G/A | View |
| 2025-05-12 | 10-Q | View |
Latest News on MLTX